On April 8, 2009, Genentech announced the withdrawal of Raptiva. Raptiva is used to treat psoriasis, a skin disorder. Raptiva is being withdrawn because patients develop the risk of contracting Progressive multifocal leukoencephalopathy, a rare and serious brain disorder. Progressive multifocal leukoencephalopathy is a rare and usually fatal viral disease that is characterized by progressive damage or inflammation to the white matter of the brain. The disease is rare and usually linked to patients with compromised immune systems due to transplants or other viral diseases.
LT Pepper Law is investigating potential cases related to Raptiva exposure. If you or a loved one has been treated with Raptiva, please consult your physican immediately. If you believe that you or a loved one were injured, please contact Luke Pepper at 267.626.7546 for a free consultation.
Facebook Badge
About Me
- Luke T. Pepper
- Luke T. Pepper focuses his practice in the areas of Mass Torts, Class Actions, Environmental Liability,Securities Litigation, Medical Malpractice and Products Liability and Settlement Administration. He also represents businesses in various capacities. He was admitted to the bar in 2001 and is admitted to practice before the Pennsylvania state courts, and the U.S. District Court for the Eastern District of Pennsylvania
No comments:
Post a Comment